Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
Status: | Completed |
---|---|
Conditions: | Psychiatric, Bipolar Disorder |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/16/2018 |
Start Date: | March 2003 |
End Date: | October 2006 |
Risperidone Plus Mood Stabilizer in the Treatment of Mixed Mania
The study aims to assess the efficacy and tolerability of risperidone added to lithium,
valproate or lamotrigine in patients experiencing a manic episode with depressive or
irritable features.
valproate or lamotrigine in patients experiencing a manic episode with depressive or
irritable features.
- The study aims to assess the efficacy and tolerability of risperidone added to lithium,
valproate or lamotrigine, or any combination of the three, in patients experiencing a
manic episode with depressive or irritable symptoms.
- To assess the back ground and baseline features associated with response/non-response to
risperidone plus mood stabilizer in patients with mania with depressive or irritable
features.
- To assess the symptomatic dimensions of response of risperidone added to mood
stabilizers in patients with mania with depressive or irritable features.
valproate or lamotrigine, or any combination of the three, in patients experiencing a
manic episode with depressive or irritable symptoms.
- To assess the back ground and baseline features associated with response/non-response to
risperidone plus mood stabilizer in patients with mania with depressive or irritable
features.
- To assess the symptomatic dimensions of response of risperidone added to mood
stabilizers in patients with mania with depressive or irritable features.
Inclusion Criteria:
- DSM IV diagnosis of bipolar disorder, currently manic, or mixed manic
- YMRS score>/= 16
- One or more of following:
1. 3 MADRS depression items scoring >/=3
2. 3 BISS depression items scoring >/=3
3. YMRS irritability and aggressive items sum score>/=4
- Taking lithium, valproate or lamotrigine at stable dose for 4 wks or longer, with
adequate serum level
- age 18 and over
- Male or female
- Inpatient or outpatient
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials